|
🐜
|
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
28 auth.
L. Gossec,
X. Baraliakos,
A. Kerschbaumer,
M. D. de Wit,
I. McInnes,
M. Dougados,
J. Primdahl,
D. McGonagle,
D. Aletaha,
A. Balanescu,
P. Bálint,
H. Bertheussen,
W. Boehncke,
G. Burmester,
J. Cañete,
...
N. Damjanov,
T. Kragstrup,
T. Kvien,
R. Landewé,
R. Lories,
H. Marzo-Ortega,
D. Poddubnyy,
Santiago Rodrigues Manica,
G. Schett,
D. Veale,
F. E. Van den Bosch,
D. M. van der Heijde,
J. Smolen
|
9 |
2020 |
9
🐜
|
|
🐜
|
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
37 auth.
J. Smolen,
Monika Schöls,
J. Braun,
M. Dougados,
O. FitzGerald,
D. Gladman,
A. Kavanaugh,
R. Landewé,
P. Mease,
J. Sieper,
T. Stamm,
M. D. de Wit,
D. Aletaha,
X. Baraliakos,
N. Betteridge,
...
F. E. Van den Bosch,
L. Coates,
P. Emery,
L. Gensler,
L. Gossec,
P. Helliwell,
Merryn Jongkees,
T. Kvien,
R. Inman,
I. McInnes,
M. Maccarone,
P. Machado,
A. Moltó,
A. Ogdie,
D. Poddubnyy,
C. Ritchlin,
M. Rudwaleit,
A. Tanew,
B. Thio,
D. Veale,
K. de Vlam,
D. M. van der Heijde
|
9 |
2017 |
9
🐜
|
|
🐜
|
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
33 auth.
S. Ramiro,
E. Nikiphorou,
A. Sepriano,
A. Ortolan,
C. Webers,
X. Baraliakos,
R. Landewé,
F. E. Van den Bosch,
B. Boteva,
A. Bremander,
P. Carron,
A. Ciurea,
F. V. van Gaalen,
P. Géher,
L. Gensler,
...
J. Hermann,
M. de Hooge,
M. Hušáková,
U. Kiltz,
C. López-Medina,
P. Machado,
H. Marzo-Ortega,
A. Moltó,
V. Navarro-Compán,
M. Nissen,
F. Pimentel-Santos,
D. Poddubnyy,
F. Proft,
M. Rudwaleit,
Mark Telkman,
S. Zhao,
N. Ziadé,
D. van der Heijde
|
8 |
2022 |
8
🐜
|
|
🦁
|
Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis.
8 auth.
D. Poddubnyy,
H. Haibel,
J. Listing,
E. Märker-Hermann,
H. Zeidler,
J. Braun,
...
J. Sieper,
M. Rudwaleit
|
8 |
2012 |
8
🦁
|
|
🐜
|
Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group
22 auth.
R. Lambert,
P. Bakker,
D. van der Heijde,
U. Weber,
M. Rudwaleit,
K. Hermann,
J. Sieper,
X. Baraliakos,
A. Bennett,
J. Braun,
...
R. Burgos-Vargas,
M. Dougados,
S. Pedersen,
A. Jurik,
W. Maksymowych,
H. Marzo-Ortega,
M. Østergaard,
D. Poddubnyy,
M. Reijnierse,
F. E. Van den Bosch,
I. E. van der Horst-Bruinsma,
R. Landewé
|
8 |
2016 |
8
🐜
|
|
🐢
|
Axial spondyloarthritis
J. Sieper,
D. Poddubnyy
|
8 |
2017 |
8
🐢
|
|
🦁
|
Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis
8 auth.
D. Poddubnyy,
M. Rudwaleit,
H. Haibel,
J. Listing,
E. Märker-Hermann,
H. Zeidler,
...
J. Braun,
J. Sieper
|
8 |
2011 |
8
🦁
|
|
🦁
|
Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
8 auth.
D. Poddubnyy,
M. Rudwaleit,
H. Haibel,
J. Listing,
E. Märker-Hermann,
H. Zeidler,
...
J. Braun,
J. Sieper
|
8 |
2012 |
8
🦁
|
|
🦁
|
Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
D. Poddubnyy,
K. Hermann,
J. Callhoff,
J. Listing,
J. Sieper
|
8 |
2014 |
8
🦁
|
|
🐜
|
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and
91 auth.
D. Heijde,
J. Wei,
M. Dougados,
P. Mease,
A. Deodhar,
W. Maksymowych,
F. Bosch,
J. Sieper,
T. Tomita,
R. Landewé,
F. Zhao,
E. Krishnan,
D. Adams,
B. Pangallo,
H. Carlier,
...
M. Churchill,
K. Flint,
G. Gladstein,
M. Greenwald,
Mary Howell,
A. Ince,
J. Kaine,
D. Mehta,
Eric Peters,
R. Querubin,
J. Reveille,
Richard Roseff,
R. Diegel,
Christine Thai,
L. Bessette,
F. Morin,
P. Rahman,
Aa Rodriguez,
F. Cons-Molina,
S. Barragan,
Cassandra C. Skinner,
C. P. Tena,
César Ramos Remus,
J. Rodriguez,
Seung-Jae Hong,
Yeon-Ah Lee,
J. Ju,
S. Kang,
Tae-Hwan Kim,
C. Lee,
E. Lee,
Sang Heon Lee,
Min-Chan Park,
K. Shin,
Sang-Hoon Lee,
Hung-An Chen,
Ying-Chou Chen,
S. Hsieh,
J. Lan,
Z. Dvořák,
R. Moravcová,
Martina Malcova,
Y. Taniguchi,
M. Kishimoto,
K. Tada,
H. Dobashi,
K. Inui,
Y. Ueki,
Y. Matsumoto,
Y. Koyama,
K. Hatta,
T. Atsumi,
H. Goto,
K. Matsui,
Y. Takakubo,
G. Neeck,
D. Poddubnyy,
A. Rubbert-Roth,
M. Szymańska,
T. Blicharski,
A. Dudek,
A. Racewicz,
R. Wojciechowski,
M. V. D. Sande,
E. Griep,
M. Nurmohamed,
G. Matsievskaya,
E. Shmidt,
M. Stanislav,
S. Yakushin,
O. Ershova,
A. Rebrov,
T. Balazs,
R. Cseuz,
E. Drescher,
G. Poór
|
7 |
2018 |
7
🐜
|
|
🐜
|
MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group
26 auth.
W. Maksymowych,
R. Lambert,
M. Østergaard,
S. Pedersen,
P. Machado,
U. Weber,
A. Bennett,
J. Braun,
R. Burgos-Vargas,
M. de Hooge,
A. Deodhar,
I. Eshed,
A. Jurik,
K. Hermann,
R. Landewé,
...
H. Marzo-Ortega,
V. Navarro-Compán,
D. Poddubnyy,
M. Reijnierse,
M. Rudwaleit,
J. Sieper,
F. E. Van den Bosch,
D. M. van der Heijde,
I. E. van der Horst-Bruinsma,
S. Wichuk,
X. Baraliakos
|
7 |
2019 |
7
🐜
|
|
🐜
|
High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis
11 auth.
Gisela Ruiz Heiland,
H. Appel,
D. Poddubnyy,
J. Zwerina,
A. Hueber,
H. Haibel,
...
X. Baraliakos,
J. Listing,
M. Rudwaleit,
G. Schett,
J. Sieper
|
7 |
2011 |
7
🐜
|
